Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. [electronic resource]
Producer: 20120827Description: 482-5 p. digitalISSN:- 1476-4687
- Acetylation -- drug effects
- Anti-HIV Agents -- therapeutic use
- Biomarkers -- metabolism
- CD4-Positive T-Lymphocytes -- cytology
- Gene Expression Regulation, Viral -- drug effects
- HIV Infections -- blood
- HIV-1 -- drug effects
- Histone Deacetylase Inhibitors -- administration & dosage
- Histones -- drug effects
- Humans
- Hydroxamic Acids -- administration & dosage
- Proviruses -- drug effects
- RNA, Viral -- biosynthesis
- Risk Assessment
- Up-Regulation -- drug effects
- Viremia -- drug therapy
- Virus Latency -- drug effects
- Vorinostat
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.